Showing results (581-590 of 2,654) with videos related to
Sort By:
Pageof 266
European Journal of Drug Metabolism and Pharmacokinetics|March 1, 2013
Genotype-phenotype correlation of cytochrome P450 2C9 polymorphism in Indian National Capital RegionEkta Varshney, Nilanjan Saha, Monika Tandon, et al.Bone|June 15, 2004
Bone mineral density and total body bone mineral content in 18- to 22-year-old womenAlmond J Drake, David W Armstrong, K M M ShakirIntegrative Cancer Therapies|March 23, 2019
Soy Isoflavones in Integrative Oncology: Increased Efficacy and Decreased Toxicity of Cancer TherapyIlyas Sahin, Birdal Bilir, Shakir Ali, et al.Cureus|February 15, 2023
Job Satisfaction Among Nurses Working in King Abdul Aziz Medical City Primary Health Care Centers: A Cross-Sectional StudyRazaz Wali, Hadeel Aljohani, Murug Shakir, et al.Georgian Medical News|May 29, 2024
TRANSPEDICULAR SCREW FIXATION IN DEGENERATIVE LUMBOSACRAL SPINE DISEASE SURGICAL OUTCOMEO Arim, A Alshalcy, M Shakir, et al.Urology Case Reports|October 26, 2020
Radical Cystectomy with Ileal Neobladder in a patient with Hemophilia! A case reportKarthik Rao, Mohan Keshavamurthy, Shakir Tabrez, et al.ACS Omega|July 3, 2026
Kinetic and Thermodynamic Analysis of Algal Lipid Extraction and Physicochemical Characterization for Biodiesel ProductionMohammad Aliff Shakir, Chen Xu, Wardah Senusi, et al.Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|November 3, 2010
Synthesis and spectroscopic studies on the Schiff base ligand derived from condensation of 2-furaldehyde and 3,3'-diaminobenzidene, L and its complexes with Co(II), Ni(II), Cu(II) and Zn(II): comparative DNA binding studies of L and its Cu(II) and Zn(II) complexesMohammad Shakir, Ambreen Abbasi, Asad U Khan, et al.Journal of the Mechanical Behavior of Biomedical Materials|August 8, 2016
Fracture characteristics of PEEK at various stress triaxialitiesFei Chen, Shakir Gatea, Hengan Ou, et al.Pharmacoepidemiology and Drug Safety|May 4, 2007
A modified prescription-event monitoring study to assess the introduction of Flixotide Evohaler into general practice in England: an example of pharmacovigilance planning and risk monitoringMichael J Perrio, Lynda V Wilton, Saad A W ShakirPageof 266